Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib + AAP vs AAP in Metastatic Prostate Cancer
NCT03748641Phase 3Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of niraparib in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Jan 2019; status: active, not recruiting.
02
Drugs
niraparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03748641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748641.